化工社化工社 化学情報印刷レポート · 研究参考用
Valproic Acid → (-)-Carnitine
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Valproic Acid | HCID 3121 | — |
| 反応物 | (-)-Carnitine | HCID 10917 | — |
| 反応物 | L-carnitine magnesium valproate | HCID 86623374 | — |
| 溶媒 | Water | HCID 962 | — |
| 生成物 | (-)-Carnitine | HCID 10917 | — |
| 生成物 | Valproate | HCID 3549980 | — |
| 生成物 | Magnesium | HCID 5462224 | — |
反応手順
As we discovered and disclose in Example 2, L-carnitine magnesium valproate, another embodiment of the present invention, is a white solid having a melting point of 77.2° C., different from the melting point of L-carnitine. The 1H-NMR spectrum of L-carnitine magnesium valproate (FIG. 3) differs from that of the starting materials (i.e., L-carnitine and valproic acid) and confirms the structure. L-carnitine magnesium valproate is nearly odorless and free from objectionable taste. L-Carnitine magnesium valproate is soluble in water, and aqueous solutions of this salt provide bioavailable L-carnitine, magnesium, and valproate.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US07456216B2 |
| 出典データセット | uspto-grants-2008_11 |
| ORD ID | ord-03713faf71dc4e8fa2470049d9690cb2 |
| 出典メモ | uspto-grants-2008_11 |